Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Bicuspid Aortic Valve
NCT02679261Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jun 2016
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bicuspid aortic valve (BAV) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change of the diameter of ascending aorta by CT at 3 years. Started Jun 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
bicuspid aortic valve (BAV)
Beyond the preview
Go deeper on NCT02679261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679261.